Catalog · Wellness

PT-141

CAS 189691-06-3MW 1,025.2 g/mol≥99.0% Purity

A melanocortin receptor agonist studied for MC3R/MC4R signaling in research models.

Quantity per vial
Vials
1
$44.99
  • Free cold-chain shipping over $200
  • Signed COA included with every vial
  • Batch-pinned ordering for protocol continuity

Research Use Only. Sold for research and identification purposes only. Not intended for human dosing, injection, or ingestion.

Mass-Spec Verified

HPLC + LC-MS per batch at Janoshik.

99% Purity Threshold

Below-spec lots are destroyed, not sold.

Cold-Chain 2–8°C

Continuous transit temperature logging.

U.S. cGMP Compounded

Domestic manufacturing, lot traceability.

Mechanism of action

PT-141 (bremelanotide) is a cyclic heptapeptide analog of α-MSH that acts as an agonist at the melanocortin receptors, principally MC3R and MC4R. Research models study its central-nervous-system melanocortin-pathway signaling.

Unlike peripheral vasoactive compounds, it is investigated for receptor-mediated central signaling, which is the focus of its research literature.

Full research overview, applications & FAQ →